PRESS RELEASE published on 07/02/2025 at 07:30, 1 year 3 months ago Informations privilégiées / Autres communiqués Communiqué de presse: Chiffre d’affaires de 2,5 M€ et trésorerie de 2,1 M€ au premier semestre 2025 pour IntegraGen. Baisse des activités et exploration stratégique pour assurer la continuité des opérations Chiffre D'affaires Stratégie Baisse Trésorerie IntegraGen
PRESS RELEASE published on 07/02/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases IntegraGen reports sales of €2.5 million in the first half of 2025, a 31% decrease in sequencing activities at Évry and challenges with cash position leading to exploration of strategic options Sales Cash Position Strategic Options IntegraGen Decrease
BRIEF published on 01/15/2025 at 18:49, 1 year 9 months ago IntegraGen revenue down for 2024 Treasury Growth Turnover Genomics SeqOIA
BRIEF published on 01/15/2025 at 18:49, 1 year 9 months ago Chiffre d'affaires d'IntegraGen en baisse pour 2024 Chiffre D'affaires Croissance Trésorerie Génomique SeqOIA
PRESS RELEASE published on 01/15/2025 at 18:44, 1 year 9 months ago Inside Information / Information on annual revenues IntegraGen, an OncoDNA Group company, reports 27% revenue drop in 2024 due to SeqOIA services cessation. Cash position at €1.9m. Growth seen outside SeqOIA Cash Position Growth Prospects Revenue Drop SeqOIA IntegraGen
PRESS RELEASE published on 01/15/2025 at 18:44, 1 year 9 months ago Informations privilégiées / Information sur chiffre d’affaires annuel IntegraGen annonce un chiffre d'affaires annuel de 8,5 M€ pour 2024, en baisse de 27%, et une trésorerie de 1,9 M€. Perspectives de croissance positives malgré la baisse due à l'arrêt de SeqOIA Chiffre D'affaires Croissance Baisse Trésorerie IntegraGen
BRIEF published on 07/18/2024 at 18:49, 2 years 3 months ago IntegraGen : Chiffre d'affaires en hausse malgré la perte de SeqOIA Chiffre D'affaires Croissance Certification CLIA Génomique SeqOIA
BRIEF published on 07/18/2024 at 18:49, 2 years 3 months ago IntegraGen: Revenue up despite loss of SeqOIA Growth Turnover CLIA Certification SeqOIA Genomic
PRESS RELEASE published on 07/18/2024 at 18:44, 2 years 3 months ago Informations privilégiées / Autres communiqués IntegraGen annonce un chiffre d'affaires de 4,5 M€ au premier semestre 2024, en hausse de 6%, avec une trésorerie de 2,8 M€. Perspectives de croissance et stratégie de réduction des coûts Chiffre D'affaires Croissance Trésorerie Certification CLIA IntegraGen
Published on 10/27/2026 at 23:40, 3 hours 5 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 3 hours 20 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/27/2026 at 21:30, 5 hours 15 minutes ago Apex Announces Closing of Over-Allotment Option
Published on 10/27/2026 at 21:15, 5 hours 30 minutes ago Goldcliff Closes First Tranche of Private PLacement
Published on 10/27/2026 at 21:10, 5 hours 35 minutes ago International Battery Metals Announces Leadership Transition
Published on 10/28/2026 at 02:25, 19 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 AGM Chair and Group CEO address
Published on 10/28/2026 at 02:19, 26 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: September 2026 quarter update
Published on 10/27/2026 at 22:40, 4 hours 4 minutes ago EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 4 hours 14 minutes ago Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 6 hours 9 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 18:00, 8 hours 45 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 8 hours 45 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
